Natixis Advisors, L.P.

SEC CIK: 0001018331
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ELV holding history

Elevance Health, Inc. in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overview All 13F holders of ELV Full Q2 2026 holdings

Shares (Q2 2026): 195,156
Value: $75.5M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of ELV by Natixis Advisors, L.P., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	195,156	$75.5M	0.1%	−16,008−7.6%	Reduced	Holders
Q1 2026	211,164	$61.8M	0.1%	−55,898−20.9%	Reduced	Holders
Q4 2025	267,062	$93.6M	0.1%	+22,267+9.1%	Added	Holders
Q3 2025	244,795	$79.1M	0.1%	+54,738+28.8%	Added	Holders
Q2 2025	190,057	$73.9M	0.1%	+24,513+14.8%	Added	Holders
Q1 2025	165,544	$72.0M	0.1%	+42,114+34.1%	Added	Holders
Q4 2024	123,430	$45.5M	0.1%	−68,666−35.7%	Reduced	Holders
Q3 2024	192,096	$99.9M	0.2%	+14,502+8.2%	Added	Holders
Q2 2024	177,594	$96.2M	0.2%	+5,662+3.3%	Added	Holders
Q1 2024	171,932	$89.2M	0.2%	+11,209+7.0%	Added	Holders
Q4 2023	160,723	$75.8M	0.2%	+17,799+12.5%	Added	Holders
Q3 2023	142,924	$62.2M	0.2%	+11,067+8.4%	Added	Holders
Q2 2023	131,857	$58.6M	0.2%	−31,490−19.3%	Reduced	Holders
Q1 2023	163,347	$75.1M	0.3%	−3,897−2.3%	Reduced	Holders
Q4 2022	167,244	$85.8M	0.3%	−18,953−10.2%	Reduced	Holders
Q3 2022	186,197	$84.6M	0.4%	+9,141+5.2%	Added	Holders
Q2 2022	177,056	$85.4M	0.4%	+1,571+0.9%	Added	Holders
Q1 2022	175,485	$86.2M	0.3%	+9,412+5.7%	Added	Holders
Q4 2021	166,073	$77.0M	0.3%	+9,077+5.8%	Added	Holders
Q3 2021	156,996	$58.5M	0.2%	−731−0.5%	Reduced	Holders
Q2 2021	157,727	$60.2M	0.3%	+5,918+3.9%	Added	Holders
Q1 2021	151,809	$54.5M	0.3%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.